Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1
by
Huang, Wei-Cong
, Liu, Yu
, Zheng, Liang-Cheng
, Zhang, Xiang
in
Angiogenesis
/ Apoptosis
/ Apoptosis; miR-125b-1-3p; Non-Small Cell Lung Cancer; S1PR1; STAT3
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Care and treatment
/ Cell Line, Tumor
/ Cell lines
/ Cell Movement
/ Cell Proliferation
/ Experiments
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genetic aspects
/ Health aspects
/ Humans
/ Lung cancer
/ Lung Neoplasms - metabolism
/ Male
/ Medical prognosis
/ Metastasis
/ MicroRNA
/ MicroRNAs - physiology
/ Middle Aged
/ Molecular targeted therapy
/ Neoplasm Invasiveness
/ Non-small cell lung cancer
/ Original
/ Polymerase chain reaction
/ Prognosis
/ Proteins
/ Studies
/ Survival analysis
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1
by
Huang, Wei-Cong
, Liu, Yu
, Zheng, Liang-Cheng
, Zhang, Xiang
in
Angiogenesis
/ Apoptosis
/ Apoptosis; miR-125b-1-3p; Non-Small Cell Lung Cancer; S1PR1; STAT3
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Care and treatment
/ Cell Line, Tumor
/ Cell lines
/ Cell Movement
/ Cell Proliferation
/ Experiments
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genetic aspects
/ Health aspects
/ Humans
/ Lung cancer
/ Lung Neoplasms - metabolism
/ Male
/ Medical prognosis
/ Metastasis
/ MicroRNA
/ MicroRNAs - physiology
/ Middle Aged
/ Molecular targeted therapy
/ Neoplasm Invasiveness
/ Non-small cell lung cancer
/ Original
/ Polymerase chain reaction
/ Prognosis
/ Proteins
/ Studies
/ Survival analysis
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1
by
Huang, Wei-Cong
, Liu, Yu
, Zheng, Liang-Cheng
, Zhang, Xiang
in
Angiogenesis
/ Apoptosis
/ Apoptosis; miR-125b-1-3p; Non-Small Cell Lung Cancer; S1PR1; STAT3
/ Carcinoma, Non-Small-Cell Lung - metabolism
/ Care and treatment
/ Cell Line, Tumor
/ Cell lines
/ Cell Movement
/ Cell Proliferation
/ Experiments
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genetic aspects
/ Health aspects
/ Humans
/ Lung cancer
/ Lung Neoplasms - metabolism
/ Male
/ Medical prognosis
/ Metastasis
/ MicroRNA
/ MicroRNAs - physiology
/ Middle Aged
/ Molecular targeted therapy
/ Neoplasm Invasiveness
/ Non-small cell lung cancer
/ Original
/ Polymerase chain reaction
/ Prognosis
/ Proteins
/ Studies
/ Survival analysis
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1
Journal Article
MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Background: MicroRNAs (miRNAs) have been extensively studied over the decades and have been identified as potential molecular targets for cancer therapy. To date, many miRNAs have been found participating in the tumorigenesis of non-small cell lung cancer (NSCLC). The present study was designed to evaluate the functions of miR-125b-1-3p in NSCLC cells.
Methods: MiR-125b-1-3p expression was detected in tissue samples from 21 NSCLC patients and in NSCLC cell lines using the real-time polymerase chain reaction. A549 cell lines were transfected with a miR-125b-1-3p mimic or miR-125b-1-3p antisense. Cell counting kit-8, wound healing, Matrigel invasion assays, and flow cytometry were used to assess the effects of these transfections on cell growth, migration, invasion, and apoptosis, respectively. Western blotting was used to detect apoptosis-related proteins, expression of S1PR1, and the phosphorylation status of STAT3. Significant differences between groups were estimated using Student's t-test or a one-way analysis of variance.
Results: MiR-125b-1-3p was downregulated in NSCLC samples and cell lines. Overexpression of miR-125b-1-3p inhibited NSCLC cell proliferation (37.8 ± 9.1%, t = 3.191, P = 0.013), migration (42.3 ± 6.7%, t = 6.321, P = 0.003), and invasion (57.6 ± 11.3%, t = 4.112, P = 0.001) and simultaneously induced more NSCLC cell apoptosis (2.76 ± 0.78 folds, t = 3.772, P = 0.001). MiR-125b-1-3p antisense resulted in completely opposite results. S1PR1 was found as the target gene of miR-125b-1-3p. Overexpression of miR-125b-1-3p inhibited S1PR1 protein expression (27.4 ± 6.1% of control, t = 4.083, P = 0.007). In addition, S1PR1 siRNA decreased STAT3 phosphorylation (16.4 ± 0.14% of control, t = 3.023, P = 0.015), as in cells overexpressing miR-125b-1-3p (16.7 ± 0.17% of control, t = 4.162, P = 0.026).
Conclusion: Our results suggest that miR-125b-1-3p exerts antitumor functions in NSCLC cells by targeting S1PR1.
Publisher
Wolters Kluwer India Pvt. Ltd,Medknow Publications and Media Pvt. Ltd,Lippincott Williams & Wilkins Ovid Technologies,Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China,Medknow Publications & Media Pvt Ltd,Wolters Kluwer
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.